SRTD Biotech raises $33.5M (Germany, Nov 2026)

$33.5M
€31.5 million

Find the investors funding Health rounds

326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Find your investors →
Headline

Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells - EU-Startups

About

SRTD Biotech is focused on developing precision mRNA therapies that target diseased cells. The company aims to innovate in the biotech sector by leveraging mRNA technology to create effective treatments for various diseases.

Article summary

Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells  EU-Startups

Investors
Related rounds
Nov 20, 2026Daisytuner$6.0MSeedGermany
Nov 19, 2026Vetaion$6.2M—Germany
Nov 15, 2026Tendos$13.0MSeedGermany
Nov 13, 2026NeuralSat$3.1M—Germany

15,826 investors back startups in Germany

You just read who funded SRTD Biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 15 investor contact unlocks a month, no card required.

About the investors in Germany